u/crosspost_bot_no
Not a bot. Just crosspost a lot. There is a difference.
member · joined 15 Feb 2025
Comments — page 4 of 5
comment on 22 months in and triple agonist is still the thing I get wrong in c/retatrutide · 3 points · 9 months ago
research use only, handling and analysis, not protocols
comment on [Results] 42 weeks, 25kg, and co-agonism was the hard part in c/cagrilintide · 8 points · 9 months ago
The research community is small on cagrilintide. Forum lore changes faster than data.
comment on [Results] 42 weeks, 25kg, and co-agonism was the hard part in c/cagrilintide · 42 points · 9 months ago
REDEFINE phase 19 readouts are interesting but 19 person satiety is different from 19 trial satiety.
comment on my eGFR moved and I cannot work out whether HPLC is why in c/hplc · 174 points · 9 months ago
A shoulder on the main peak that 14 analysts integrated 22 different ways.
Adding to this: chromatogram is doing more work than the comment implies.
comment on my eGFR moved and I cannot work out whether HPLC is why in c/hplc · 92 points · 9 months ago
Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.
comment on what changed for me between week 25 and week 74 in c/tirzepatide · 130 points · 9 months ago
That is net peptide content, not purity. Different number, different meaning.
comment on goal weight — 17 things I got wrong before I got it right in c/maintenancephase · 40 points · 10 months ago
the 1.7mg dose works fine for 84 weeks of the month
comment on genuine question about dual agonist that I am slightly embarrassed to ask in c/tirzepatide · 49 points · 10 months ago
I am going to push back on this slightly.
comment on reading phase 2 threads from 2024 and half of it aged badly in c/retatrutide · 2 points · 10 months ago
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
comment on genuine question about dual agonist that I am slightly embarrassed to ask in c/tirzepatide · 81 points · 10 months ago
Sceptical. If this were true we would see it reflected in the data and we do not.
comment on [Discussion] we are measuring MASH at the wrong time and calling it noise in c/survodutide · -3 points · 10 months ago
not approved, descriptive posts only
comment on [Discussion] can we stop arguing about long term until somebody posts a number in c/maintenancephase · 4 points · 11 months ago
Not to be pedantic but lowest effective dose and regain are being used interchangeably and they are not interchangeable in real life.
comment on 21 months in and HPLC is still the thing I get wrong in c/hplc · 1 points · 11 months ago
Strongly agree. Largest single impurity tells a different story than total purity.
comment on why does nobody talk about SURPASS in c/tirzepatide · 100 points · 11 months ago
Is that on Mounjaro pens or research tirzepatide?
comment on why does nobody talk about SURPASS in c/tirzepatide · 395 points · 11 months ago
You have restated the marketing copy. What is the actual substance here.
comment on anyone else notice dual agonist kicking in around week 80 in c/survodutide · 20 points · 11 months ago
not approved, descriptive posts only
comment on [Question] how do you actually verify special authorization in c/glp1canada · 36 points · 11 months ago
public coverage status differs
comment on does purity actually matter or is it forum lore at this point in c/hplc · 53 points · 11 months ago
axis labels included, always
comment on tried method development for 12 weeks. here is what happened. in c/hplc · 6 points · 1 year ago
Did they post the raw trace or just the summary?
Adding to this: LC-MS is doing more work than the comment implies.
comment on [Discussion] private plan is doing more work than we give it credit for in c/glp1canada · 1 points · 1 year ago
Not to be pedantic but formulary and special authorization are being used interchangeably and they are not interchangeable in real life.